Cargando…
Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
BACKGROUND: Increased risk and cancer-related mortality is observed in pancreatic cancer (PC) patients with diabetes mellitus (DM). Whether using metformin as glucose-lowering therapy can result in survival benefit in this group of patients is still unclear. METHODS: A meta-analysis of 21 studies th...
Autores principales: | Shi, Yu-Qi, Zhou, Xiao-Chong, Du, Peng, Yin, Min-Yue, Xu, Lan, Chen, Wen-Jie, Xu, Chun-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489714/ https://www.ncbi.nlm.nih.gov/pubmed/32925714 http://dx.doi.org/10.1097/MD.0000000000021687 |
Ejemplares similares
-
Effect of Body Mass Index on Overall Survival of Pancreatic Cancer: A Meta-Analysis
por: Shi, Yu-Qi, et al.
Publicado: (2016) -
Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016) -
Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: A network meta-analysis
por: Shou-xin, Yin, et al.
Publicado: (2020) -
Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer: A meta-analysis
por: Zang, Ye, et al.
Publicado: (2020) -
The Gastric/Pancreatic Amylase Ratio Predicts Postoperative Pancreatic Fistula With High Sensitivity and Specificity
por: Jin, Shuo, et al.
Publicado: (2015)